Exploring Trends in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) Therapy Utilization based on Race, Gender, and Region using Real-World Data
Authors: Tiba Qattan, Kajal Bhauryal*
Affiliation: Ironwood Pharmaceuticals, Boston, MA
*Author list not exhaustive; additional contributors may be included in the final manuscript.
Virtual Care for Rare Diseases explores how innovative virtual care solutions can address the unique challenges faced by patients with rare diseases. It examines the barriers such as limited access to specialists, delayed diagnoses, and financial burdens while highlighting the potential of telemedicine, telehealth, and remote patient monitoring to improve accessibility, equity, and healthcare outcomes. The study emphasizes policy changes needed for sustainable and efficient virtual care models, proposes research priorities, and emphasizes the transformative role of virtual care in enhancing the quality of life for patients with rare diseases.
India’s pursuit of health-related Sustainable Development Goals is deeply shaped by its political economy, from colonial exploitation to neoliberal reforms. Persistent health inequities, workforce shortages, and underfunded systems reveal the urgent need for structural realignment and inclusive policy action.
The co-occurrence of Type 2 Diabetes Mellitus and cardiovascular diseases is a growing public health crisis in Sub-Saharan Africa, marked by rising prevalence and early mortality. Effective response demands integrated care models, targeted prevention strategies, and increased investment in non-communicable disease infrastructure.
Transforming cancer outcomes in sub-Saharan Africa depends on embedding community engagement at the core of oncology research. Without culturally informed, participatory strategies, cancer control efforts will continue to fall short of the region’s urgent needs.
Physician burnout is a growing public health crisis, driven by systemic challenges and worsened by moral distress and administrative burdens. Addressing it requires coordinated policy, organizational reform, and sustained investment in physician well-being and healthcare equity.
Digital therapeutics (DTx) are reshaping depression care by delivering evidence-based, software-driven treatments that improve access, adherence, and outcomes. With rising global demand for mental health support, DTx offers scalable, affordable, and stigma-free interventions backed by clinical trials and real-world efficacy.
Read full text